About 92% of participants lost more than 10% of their body weight, and 84% lost more than 15%
High-quality printing and consistent design are indicative of a genuine product
Hankosky, PhD, senior director of Cardiometabolic Health, Health Economics and Outcomes Research at Eli Lilly & Company, and corresponding author of this study, confirmed for Medical News Today that the participants were taking Mounjaro as an off-label treatment for weight management at the discretion of their prescribing physician. During their study, researchers also reported that about 32% of participants who started tirzepatide had class 3 obesity with a BMI of 40 kg/m 2 or more
Other common additives in compounded semaglutide formulations Methylcobalamin is not the only ingredient pharmacies add to semaglutide
However, individual cases do occur, often linked to blood sugar changes, dehydration, or blood pressure shifts rather than a direct drug effect
Figure 4 Statements Author contributions J-YM documented paper, drew figures, and summarized data